PI3Kとヘッジホッグシグナル伝達経路の抑制は,卵巣がん幹細胞における低酸素誘発の血管新生ミミクリ形成を抑制する
Jun Liang1, Yun Bai1, Huan Zhao1
1Department of Obstetrics and Gynecology, Hebei Medical University Third Hospital, Hebei Province, China.
Balkan medical journal
|September 1, 2025
まとめ
低酸素誘導因子-1α (HIF-1α) はPI3K/ AKTとヘッジホッグ経路を活性化させ,卵巣がん幹細胞 (OCSC) の血管新生ミミクリ (VM) を促進する. これらの経路を阻害すると VMが減少し,卵巣がんの潜在的治療標的となる.
科学分野:
- 腫瘍学
- 分子生物学
- 癌 幹 細胞 研究
背景:
- ヘッジホッグとPI3K/AKTのシグナル伝達経路は,腫瘍増殖と幹細胞活動を抑制することが知られている.
- 卵巣がん幹細胞 (OCSCs) による血管新生模倣 (VM) に関するこれらの経路の特定の役割は十分に理解されていません.
研究 の 目的:
- OCSC内のVM形成におけるPI3K/AKTとヘッジホッグ信号の関与を調査する.
- OCSCにおけるVMを駆動する基本的な分子メカニズムを解明する.
主な方法:
- OCSCsは生成され,低毒状態にさらされた.
- 低酸素誘導因子-1α (HIF-1α) のノックダウンが行われました.
- 細胞は経路特異なアゴニストおよび阻害剤 (PI3K/ AKTおよびヘッジホッグ経路) で治療された.
- 主要マーカー (HIF- 1α,上皮から内皮への移行マーカー,経路成分) の発現を分析した.
- VMの容量,増殖,侵入は,in vitroおよびin vivoモデルを使用して評価されました.
主要な成果:
- OCSCにおけるPI3K/ AKTとヘッジホッグ経路を活性化させ,HIF- 1αの発現を著しく増加させた.
- HIF- 1αのノックダウンはこれらの経路を抑制し,VMに関連するマーカー (N- カデリン,VE- カデリン) の低酸素誘発のアップレギュレーションを阻害しました.
- PI3K/ AKTとヘッジホッグ経路の抑制は,HIF- 1αのノックダウンとともに,VMの形成,細胞増殖,およびインビトロおよびインビボでの侵入を著しく減少させた.
結論:
- HIF-1αは,OCSCの低毒性条件下でPI3K/AKTとヘッジホッグのシグナリングを活性化するのに重要な役割を果たします.
- HIF- 1αの抑制は,上皮から内皮への移行とVMの形成を効果的に減少させます.
- HIF-1α,PI3K/AKT,およびヘッジホッグ経路をターゲットにすることは,卵巣がんにおけるVMを抑制する有望な戦略です.
関連する概念動画
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
Hedgehog Signaling Pathway
7.5K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.5K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Mechanism of Angiogenesis
5.8K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.8K


